09-Feb-2021
Download PDF
Aurobindo Pharma
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we inform you that an analyst / investor call on the Unaudited Financial Results of the Company for the third quarter and nine months period ended 31st December 2020 is scheduled on 11th February 2021 at 08:30 hrs.
Please find attached the dial-in details of the call.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
